Search
for
Sort by
Research 211–240 of 1000+
- Pharmacological management of polycystic ovary syndrome
- Present Chemotherapy Induced Alopecia and Research in Future
- Clinical Development of Topoisomerase-Interactive Drugs
- Health hazard evaluation report: HETA-2000-0385-2813, Equifax Payment Services, St. Petersburg, Florida.
- The PDGF/PDGFR pathway as a drug target
- Vitamin E TPGS based transferosomes augmented TAT as a promising delivery system for improved transdermal delivery of raloxifene
- Roles of Wnt7a in embryo development, tissue homeostasis, and human diseases
- Table_2.docx
- Table_1.docx
- Tumor Angiogenesis and Anti-angiogenic Therapy
- Trailing the Path to Preventive Oncology
- Somatic Mutations in Normal Tissues: New Perspectives on Early Carcinogenesis
- The ITGB6 gene: its role in experimental and clinical biology
- Targeting of Smoothened for therapeutic gain
- Application and Progress of Cultured Models of Gallbladder Carcinoma
- Moving Chemoprevention Forward into the Most Promising Areas of Study
- Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies
- Current Management and Treatment Options for Breast Pain
- Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies
- Paclitaxel/Platinum combination regimen and alopecia
- Potential Consequences of the Use of Adipose-Derived Stem Cells in the Treatment of Hepatocellular Carcinoma
- Regulation of stem cell function by protein ubiquitylation
- Oral Presentations: Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia
- The diagnostic algorithm in pre-invasive cervical lesions
- The Dickkopf Protein Family in Non-Neoplastic Disorders: Emerging Roles and Therapeutic Targeting
- Low-Dose Oral Minoxidil During Chemotherapy: A Review of the Mechanism and Current Evidence
- Erratum
- Local heroes or villains: tissue-resident memory T cells in human health and disease
- Harnessing Microbiome, Bacterial Extracellular Vesicle, and Artificial Intelligence for Polycystic Ovary Syndrome Diagnosis and Management
- Sacituzumab Govitecan-Hziy (Trodelvy™)